Get a reply from this employer — a resume and cover letter tailored to exactly what they’re hiring for.
Cogent Biosciences, Inc. is seeking a Senior Director, Global Market Access to develop and execute market access strategies enabling patients to access innovative therapies. This global role includes US market responsibilities and close collaboration with HEOR capabilities to support payer decision-making.
The ideal candidate has oncology market access experience, strong payer/reimbursement understanding, and a hands-on approach to drive execution with lean resources and external partners.
Cogent Biosciences is a publicly traded biotechnology company focused on developing novel precision therapies to treat a broad range of patients with unmet medical needs. Cogent's lead program, bezuclastinib, is designed to selectively and potently inhibit exon 17 mutations found within the KIT receptor tyrosine kinase, including KIT D816V. KIT D816V is responsible for driving a rare and serious condition called Systemic Mastocytosis, and exon 17 mutations are also found in patients with gastrointestinal stromal tumors (GIST), a type of cancer with strong dependence on oncogenic KIT signaling. Bezuclastinib has exhibited promising initial data across all three trials: APEX in AdvSM, SUMMIT in NonAdvSM and PEAK in GIST, including an encouraging safety profile across 600+ patients in single agent and combination dosing.
Cogent Biosciences is seeking an entrepreneurial and strategic Senior Director, Global Market Access to develop and execute market access strategies that enable patients with cancer to access innovative therapies.
Reporting to the Vice President, Value & Access Strategy, this role will have a global remit with some responsibility for the US market. The Sr. Director will work across the organization to translate clinical and economic value into compelling market access strategies across key markets.
The role will partner closely with Commercial, Medical Affairs, Clinical Development, Regulatory, Finance, and other cross-functional teams, while working closely with the company's HEOR capabilities within the Value & Access organization to develop evidence and value strategies that support payer and HTA decision-making.
The ideal candidate brings strong oncology market access experience, a solid understanding of payer and reimbursement dynamics, and experience developing access strategies across international markets. This is a highly visible, hands‑on role in a growing biotech environment, requiring both strategic thinking and the ability to drive execution with lean internal resources and external partners.
Global Market Access & Value Strategy
Evidence, HEOR & Oncology Value Strategy
Pricing & Reimbursement
Launch Readiness
$260,000 to $305,000 USD
Target Bonus: 25%
Exact compensation will vary based on skills, experience, and location.
Waltham, MA: Our headquarters is located in the Greater Boston life sciences community, with an open, collaborative office environment designed to support teamwork and connection. Employees benefit from convenient on‑site amenities, including free on‑site parking and gym facilities in the building.
Boulder, CO: Our Boulder location is home to Cogent’s discovery research organization and a key scientific hub with strong leadership based on site. Situated in the greater Denver‑Boulder biopharmaceutical corridor, this office plays a central role in advancing our discovery efforts and pipeline.
We are proud to be an Equal Opportunity Employer. Our goal is to have a diverse workforce. We do not discriminate on the basis of race, age, color, religion, national origin, gender, sexual orientation, gender identity or expression, veteran status or disability, or any other status protected under federal, state, or local law. All employment is decided on the basis of qualifications, merit, and business need.